Skip to Content

NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer

Posted on June 17, 2013

Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.  The results of this study, carried out by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, in collaboration with the International Agency for Research on Cancer (IARC), were published online June 17,  2013, in the Journal of Clinical Oncology.

News Items

NCI Press Release: NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer

The National Cancer Institute (NCI) press release for the study

Information for Journalists

To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:

E-mail:
ncipressofficers@
mail.nih.gov

Phone: 301-496-6641